Company attributes
Venture Capital Firm attributes
Other attributes
RA Capital Management is a venture capital and private equity firm investing in public and private healthcare and life science companies that is headquartered in Boston, Massachusetts and was founded in 2004 by Richard Aldrich.
As of December 2019, RA Capital Management has made 114 investments, lead 28 investments, and made a total of 62 exits. Notable investments made by Ra Capital Management (as of December 2019) include: Audentes Therapeutics, 89bio, Bluebird Bio, Precision BioSciences, Moderna Therapeutics, Peloton Therapeutics, Orchard Therapeutics, Phathom Pharmaceuticals, Global Blood Therapeutics, and AveXis.
On July 15, 2019 RA Capital Management announced raising $308 million for their RA Capital Nexus Fund. The fund increases the firms deal capiacity to $1 billion, and the total managed assets to about $2.5 billion. The firms plans on using the fund to invest in companies working on products and services realted to neurology, oncology, cardiovascular disease, and rare diseases.
